Contraception
Volume 85, Issue 2 , Pages 144-149 , February 2012

Safety of digoxin for fetal demise before second-trimester abortion by dilation and evacuation

  • Gillian Dean

      Affiliations

    • Planned Parenthood of New York City, New York, NY 10012, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 274 7324; fax: +1 212 274 7218.
    • ,
  • Lisa Colarossi

      Affiliations

    • Planned Parenthood of New York City, New York, NY 10012, USA
    • ,
  • Britt Lunde

      Affiliations

    • Department of Obstetrics and Gynecology, University of Illinois, Chicago, IL, USA
    • ,
  • Adam R. Jacobs

      Affiliations

    • Department of Obstetrics, Gynecology, and Reproductive Sciences, The Mount Sinai Medical Center, New York, NY 10029, USA
    • ,
  • Lauren M. Porsch

      Affiliations

    • Planned Parenthood of New York City, New York, NY 10012, USA
    • ,
  • Maureen E. Paul

      Affiliations

    • Planned Parenthood of New York City, New York, NY 10012, USA

Received 1 February 2011 ,Revised 19 May 2011 ,Accepted 21 May 2011.

References 

  1. Diedrich J, Drey E, Society of Family Planning . Induction of fetal demise before abortion. Contraception. 2010;81:462–473
  2. Gonzales v. Carhart, 550 U.S. 124 (2007).
  3. Jackson RA, Teplin VL, Drey EA, Thomas LJ, Darney PD. Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol. 2001;97:471–476
  4. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007;45:247–251
  5. Knoke D, Burke PJ. Log-linear models. Thousand Oaks (CA): Sage; 1980;
  6. McAlister FA, Straus SE, Guyatt GH, Haynes RB. Evidence-Based Medicine Working Group. Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. JAMA. 2000;283:2829–2836
  7. Drey EA, Thomas LJ, Benowitz NL, Goldschlager N, Darney PD. Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation. Am J Obstet Gynecol. 2000;182:1063–1066
  8. Molaei M, Jones HE, Weiselberg T, McManama M, Bassell J, Westhoff C. Effectiveness and safety of digoxin to induce fetal demise prior to second trimester abortion. Contraception. 2008;77:223–225
  9. Hern WH. Laminaria, induced fetal demise and misoprostol in late abortion. Int J Gynaecol Obstet. 2001;75:279–286
  10. Hern WH, Zen C, Ferguson KA, et al. Outpatient abortion for fetal anomaly and fetal death from 15–34 menstrual weeks' gestation: techniques and clinical management. Obstet Gynecol. 1993;81:301–306
  11. Nucatola D, Roth N, Gatter M. A randomized pilot study on the effectiveness and side effect profiles of two doses of digoxin as fetocide when administered intraamniotically or intrafetally prior to second-trimester surgical abortion. Contraception. 2010;81:67–74
  12. Grimes DA, Schulz KF, Cates W, Tyler CA. Midtrimester abortion by dilatation and evacuation: a safe and practical alternative. N Engl J Med. 1977;296:1141–1145
  13. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol. 1983;62:185–190
  14. Hern WM. Laminaria versus Dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: randomized cohort comparison of 1001 patients. Am J Obstet Gynecol. 1994;171:1324–1328
  15. Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol. 2006;108:1067–1072
  16. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol. 2007;110:687–694
  17. Patel A, Rashid S, Godfrey EM, Panchal H. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae genital infections in a publicly funded pregnancy termination clinic: empiric vs. indicated treatment?. Contraception. 2008;78:328–331
  18. Roper EC, Konje JC, De Chazel RC, Duckett DP, Oppenhimer CA, Tayler DJ. Genetic amniocentesis: gestation-specific pregnancy outcome and comparison of outcome following early and traditional amniocentesis. Prenat Diagn. 1999;19:803–807

PII: S0010-7824(11)00252-6

doi: 10.1016/j.contraception.2011.05.016

Contraception
Volume 85, Issue 2 , Pages 144-149 , February 2012

Article Tools

* Image Usage & Resolution